Ubs Oconnor LLC Teva Pharmaceutical Industries LTD Transaction History
Ubs Oconnor LLC
- $1.72 Billion
- Q2 2024
A detailed history of Ubs Oconnor LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ubs Oconnor LLC holds 50,896 shares of TEVA stock, worth $909,511. This represents 0.05% of its overall portfolio holdings.
Number of Shares
50,896Holding current value
$909,511% of portfolio
0.05%Shares
6 transactions
Others Institutions Holding TEVA
# of Institutions
603Shares Held
567MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$768 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$649 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$578 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$520 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$515 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...